Blue Light for Treating Eczema
Monocenter, Randomized, Intraindividual, Open Label, Exploratory Study Comparing 4 Weeks of Treatment With 453nm Blue Light With no Treatment in Patients With Eczema
Sponsor: Philips Electronics Nederland BV
Listed as NCT02002871, this NA trial focuses on Eczema and remains completed. Sponsored by Philips Electronics Nederland BV, it has been updated 9 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
-
Jan 2021 — Dec 2022 [monthly]
Completed NA
▶ Show 4 earlier versions
-
May 2019 — Jan 2021 [monthly]
Completed NA
-
Jun 2018 — May 2019 [monthly]
Completed NA
-
May 2017 — Jun 2018 [monthly]
Completed NA
-
Jan 2017 — May 2017 [monthly]
Completed NA
First recorded
Oct 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Philips Electronics Nederland BV
For direct contact, visit the study record on ClinicalTrials.gov .